ISSN : 2471-304x
Kimihiko Okazaki
Okazaki Medical Clinic, Japan
Posters & Accepted Abstracts: J Clin Immunol Allergy
DOI: 10.21767/2471-304X-C1-009
According to the traditional concept of the contemporary immunology, neither autoimmune diseases nor allergic diseases can be cured completely. Nevertheless, a fortunate coincidence led the author to discover a novel concept that eliminations of the causes of these diseases are possible. In other words, combinations of pathogenic antibodies with responsible cells, namely, cytolytic T lymphocytes in cases of autoimmune diseases and mast cells in cases of allergic diseases, can be decomposed by replacing the pathogenic antibodies with non-specific antibodies. In more detail, intradermal injections with a non-specific antigen preparation induce productions of nonspecific antibodies in the body of the patient. Repetitions of the injections bring about an accumulation of them. Accumulated non-specific antibodies will occupy most of the receptors on the surface of responsible cells. When the accumulation reaches the sufficient level, virtually no pathogenic antibodies would remain on the receptors. That is, no causes of the diseases remain.
Kimihiko Okazaki has completed his Graduation from Kyoto University, Faculty of Medicine in 1959. He was engaged in medical chemical research from Apr’ 1960 to Jul’ 1981. He has started working in Internal Medicine in July, 1981. He has started running a private medical clinic in Sep’ 1989. His main achievements are as follows: discovery of a novel in coenzyme of thiamine pyrophosphokinase Baker’s yeast; identification of initiator of rat liver regeneration as biliverdin and discovery of a novel and complete cure-method for allergic and autoimmune diseases.
E-mail: ma13081x@ma1.seikyou.ne.jp
Journal of Clinical Immunology and Allergy received 16 citations as per Google Scholar report